in

Biodefense News Headlines of the Week – February 15, 2015

Global Biodefense News BSL 4 WorkerMitigating the risks of synthetic biology | Saudi Arabia confirms 8 new MERS cases | Top Iraqi scientist visits Mason to study and present on biorisk management | From the Lorax to the laboratory | The U.S. helped beat back Ebola — only not in the way you might think | Fact-checking vaccines and measles | There’s no plague in the NYC subway. No platypuses either | Allen Foundation responds nimbly as Ebola epidemic shifts | ‘Positive’ results for Ebola drug upsets plans for trials | Scientists study teeth and gerbils to further understand plague | Experimental Ebola drug protects 75 percent of monkeys in study | DHS experts discuss future of nuclear/radiological equipment at ports | How long is an Ebola victim’s body contagious? You don’t want to know | The digital health revolution | CDC: Flu slowing but on track for marathon season | Doctors who minimize measles should lose their licenses | Reforming WHO in a time of Ebola | Sierra Leone loses track of millions in Ebola funds | Lab on a chip turns smart phones into mobile disease clinics | New collaborations tackle bioscience big data challenges | Ebola drug ZMapp ready for testing in Africa | Vaccine incentives proposed for doctors to woo parents | ‘Positive’ results for Ebola drug upsets plans for trials | ECDC calls for field epidemiologists to join activities in Guinea | Nigeria is on the verge of bidding goodbye to polio | Persevering past roadblocks to build promising Ebola vaccine | Postmortem stability of Ebola virus

See what we’re reading this week at Global Biodefense on biorisk management, MERS-CoV, the measles epidemic, vaccine debate and more…

Mitigating the risks of synthetic biology (Council on Foreign Relations)

Saudi Arabia confirms 8 new MERS cases (CIDRAP)

Top Iraqi scientist visits Mason to study and present on biorisk management (GMU)

From the Lorax to the laboratory (APHL)

The U.S. helped beat back Ebola — only not in the way you might think (NPR)

Fact-checking vaccines and measles (PolitiFact)

There’s no plague in the NYC subway. No platypuses either (Nat Geographic)

Allen Foundation responds nimbly as Ebola epidemic shifts (Seattle Times)

‘Positive’ results for Ebola drug upsets plans for trials (Science)

Scientists study teeth and gerbils to further understand plague (MNT)

Experimental Ebola drug protects 75 percent of monkeys in study (Huff Post)

DHS experts discuss future of nuclear/radiological equipment at ports (GSN)

How long is an Ebola victim’s body contagious? You don’t want to know (NPR)

The digital health revolution (Commonwealth Fund)

CDC: Flu slowing but on track for marathon season (CIDRAP)

Doctors who minimize measles should lose their licenses (Time)

Reforming WHO in a time of Ebola (The Bifurcated Needle)

Sierra Leone loses track of millions in Ebola funds (NY Times)

Lab on a chip turns smart phones into mobile disease clinics (Science)

New collaborations tackle bioscience big data challenges (BBSRC)

Ebola drug ZMapp ready for testing in Africa (NBC News)

Vaccine incentives proposed for doctors to woo parents (Bloomberg)

‘Positive’ results for Ebola drug upsets plans for trials (Science)

ECDC calls for field epidemiologists to join activities in Guinea (Eurosurveillance)

Nigeria is on the verge of bidding goodbye to polio (NPR)

Persevering past roadblocks to build promising Ebola vaccine (KLAS Las Vegas)

Postmortem stability of Ebola virus (EID Journal)

HazMat First Responders

Market Survey: Disaster Response Information Programs

Archie Clements, Australian National University

Tracking Parasites with Satellites